Posts Tagged ‘endpoints’

RSS

March 12th, 2014

Clinical Trials For Diabetes Drugs Need To Consider Heart Failure

Is heart failure the missing 800 pound gorilla in diabetes trials? That’s the argument proposed by a group of  prominent cardiovascular and diabetes researchers. It was long believed that by virtue of their glucose-lowering properties diabetes drugs would confer substantial cardiovascular benefits. That belief is no longer widely held, however, and the FDA now requires cardiovascular […]